LED face masks · head to head

Nanoleaf LED Light Therapy Face Mask vs
Omnilux Contour Face

Two of the nine LED face masks in our comparison table, side by side. Every figure below is one the manufacturer publishes itself; where a brand stays silent the cell says so.

The short answer

The Nanoleaf LED Light Therapy Face Mask emits at 640 nm, 850 nm. The Omnilux Contour Face emits at 633 nm, 830 nm. Both cover red and near-infrared, the two ranges with the strongest published evidence for skin.

Neither brand publishes an irradiance figure, so the dose the two masks deliver cannot be compared from the specification sheets.

Side by side

The specifications

Manufacturer-published specifications, checked 19 August 2026.
Specification Nanoleaf LED Light Therapy Face Mask Omnilux Contour Face
Wavelengths640 nm850 nm633 nm830 nm
LEDs432132
Published irradianceNot publishedNot published
Dose per session
Session10–20 min10 min
Modes7 modesSingle programme, 3–5×/week
RegulatoryFDA cleared · CEFDA cleared · CE · TGA (Australia)
FitFlexibleFlexible silicone
PowerRechargeableRechargeable controller
Price (EU)€149.99
€0.35 per LED
€453.75
€3.44 per LED

“Published irradiance” means the brand prints an output figure on its own product page. “FDA cleared” is not “FDA approved” — see the questions below.

Where they differ

Wavelengths
The Nanoleaf LED Light Therapy Face Mask emits at 640 nm, 850 nm. The Omnilux Contour Face emits at 633 nm, 830 nm. Both cover red and near-infrared, the two ranges with the strongest published evidence for skin.
LED count
The Nanoleaf LED Light Therapy Face Mask carries more diodes: 432 against 132. Diode count sets how evenly light reaches the face — a coverage figure, not an efficacy figure.
Published irradiance
Neither brand publishes an irradiance figure, so the dose the two masks deliver cannot be compared from the specification sheets.
Regulatory
Neither prints a searchable 510(k) number; both state their clearance without one. These devices are FDA cleared, not FDA approved — clearance is a safety and manufacturing signal, not proof of results.
Session and modes
The Nanoleaf LED Light Therapy Face Mask runs 10–20 min per session (7 modes). The Omnilux Contour Face runs 10 min (single programme, 3–5×/week).
Fit and power
Nanoleaf LED Light Therapy Face Mask: flexible; rechargeable. Omnilux Contour Face: flexible silicone; rechargeable controller.

Evidence notes

What the specifications don’t tell you

Nanoleaf LED Light Therapy Face Mask

The Nanoleaf LED Light Therapy Face Mask uses 432 LEDs at 640 nm, 850 nm, in sessions of 10–20 min.

FDA cleared with the second-highest diode count here, but 640/850 nm sit slightly off the most-studied 633/830 nm peaks, and the build is less substantial than the silicone masks.

Omnilux Contour Face

The Omnilux Contour Face uses 132 LEDs at 633 nm, 830 nm, in sessions of 10 min.

The Omnilux LED platform is referenced across 40+ peer-reviewed papers over 20+ years — the deepest clinical heritage in the category, though consumer-mask-specific data is still brand-linked.

Questions

Common questions

What is the main specification difference between the Nanoleaf LED Light Therapy Face Mask and the Omnilux Contour Face?

The Nanoleaf LED Light Therapy Face Mask emits at 640 nm, 850 nm. The Omnilux Contour Face emits at 633 nm, 830 nm. Both cover red and near-infrared, the two ranges with the strongest published evidence for skin.

Neither brand publishes an irradiance figure, so the dose the two masks deliver cannot be compared from the specification sheets.

Which has more LEDs, the Nanoleaf LED Light Therapy Face Mask or the Omnilux Contour Face?

The Nanoleaf LED Light Therapy Face Mask carries more diodes: 432 against 132. Diode count sets how evenly light reaches the face — a coverage figure, not an efficacy figure.

Are the Nanoleaf LED Light Therapy Face Mask and the Omnilux Contour Face FDA cleared?

Nanoleaf LED Light Therapy Face Mask: FDA cleared · CE. Omnilux Contour Face: FDA cleared · CE · TGA (Australia). Clearance under section 510(k) means the manufacturer showed substantial equivalence to a device already on the market and met safety standards — it is not FDA approval, and it is not evidence of efficacy.